Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.
Submissions from 2026
8-1-2026 POSTER: AML-1733: Trends in Acute Myeloid Leukemia Mortality Among Female Patients in the United States, 1999–2020: A Population-Based Analysis of Average Annual Percent Change, Krishna Sajeev, Rochester Regional Health, Sai Varun Gadde, FNU Bhuvan, et al.
8-1-2026 POSTER: AML-1737: Pneumonia as a Contributing Cause of Death in Acute Myeloid Leukemia Patients: A 22-Year Population-Based Analysis of Trends in the United States, 1999–2020, Rutvij Solanki, Parth Desai, Yojan Chandra Reddy Vennapusa, et al.
8-1-2026 POSTER: AML-1739: Racial Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018–2024: A Nationwide Trend Analysis Across 15 Racial Groups, Sai Varun Gadde, Krishna Sajeev, Rochester Regional Health, FNU Bhuvan, et al.
8-1-2026 POSTER: CLL-046: Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Chronic Lymphocytic Leukemia Patients (2017–2021), Toluwani Balogun, Rochester Regional Health, Purva Shah, Rochester Regional Health, Vasudha Garg, Rochester Regional Health, et al.
8-1-2026 POSTER: CLL-1558: Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis, Mutasim Idriss, Rochester Regional Health, Summiya Nasim, Muhammad Junaid, et al.
8-1-2026 POSTER: MCL-668: Infectious Complications in Patients With Mantle Cell Lymphoma Treated With CAR-T Therapy: A Real-World TriNetX Analysis, Anushree Venkatesh Murthy, Rochester Regional Health, Adithya Nagendran, Rochester Regional Health, Logesh Durairaj, Rochester Regional Health, et al.
8-1-2026 POSTER: MM-1033: Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 POSTER: MM-1033: Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 POSTER: MM-1400: Disseminated Intravascular Coagulation in Multiple Myeloma: A Nationwide Analysis of Mortality, Organ Failure, and Healthcare Utilization, Jawad Ahmed, Dua Azim, Rochester Regional Health, Abdul Ghani Iqbal, et al.
8-1-2026 POSTER: MM-1692: Global, Regional, and National Macroeconomic Burden of Multiple Myeloma: An Age-Stratified Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Hardik Dineshbhai Desai, Digantkumar Patel, Aditya Ahuja, et al.
8-1-2026 POSTER: MM-1738: Three Decades of Rising Disparity: Global Burden, Temporal Trends, and Sociodemographic Inequities of Multiple Myeloma in Women, 1990–2023, Deep Sangani, FNU Bhuvan, Sai Varun Gadde, et al.
8-1-2026 POSTER: MM-1740: Narrowing Burden, Widening Gaps: A 26-Year Population-Based Analysis of Renal Failure as Contributing Cause of Death in Multiple Myeloma, 1999–2024, FNU Bhuvan, Sai Varun Gadde, Krishna Sajeev, Rochester Regional Health, et al.
8-1-2026 Real-world Clinical and Diagnostic Features of Patients With Isolated Anti-SSB Antibodies Compared With Those With Combined Anti-SSA and Anti-SSB Antibodies, Massiel Jimenez, Asim Khanfar, Rochester Regional Health, Pratibha Chaudhary, et al.
8-1-2026 Spontaneous Migration of a Postcholecystectomy Surgical Clip From the Common Bile Duct to the Cecum Nineteen Years After Surgery: A Case Report, Marina Takawy, Rochester Regional Health, Tausif Syed, Rochester Regional Health, Mostafa Najim, Rochester Regional Health, et al.
8-1-2026 Workforce Perception and Awareness of Sustainability in Gastrointestinal Endoscopy: A Systematic Review of Green Endoscopy, Hareesha Rishab Bharadwaj, Syed Hasham Ali, Thai Hau Koo, et al.
7-14-2026 Clinicopathologic features, treatment patterns and survival outcomes of acinic cell carcinoma of the breast: a national cancer database analysis., Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Akshjot Puri, et al.
7-6-2026 Disparities in palliative care settings among patients with renal cell carcinoma in the United States: a nationwide population-based study, Cher Ying Foo, Rochester Regional Health; Ojasav Sehrawat, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health
7-1-2026 Clinicopathologic features, treatment patterns, and survival outcomes of glycogen-rich clear cell carcinoma of the breast: A National Cancer Database Analysis, Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Waqar Haque, et al.
7-1-2026 Comparative outcomes and characteristics of biliary, alcoholic and drug-induced pancreatitis based on the National Inpatient Sample (2016-2021), Omar Alkasabrah, Sameeha Ibrahim, Abdullah Hafeez, et al.
7-1-2026 Drug-induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge, Kavya Balusu, Rochester Regional Health, Syed Usman Mohsin Ehsanullah, Rochester Regional Health, Jennifer Olejniczak, Rochester Regional Health, et al.
7-1-2026 Gastrointestinal and Hepatobiliary Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes, Chengu Niu, Rochester Regional Health, Kefang Sun, Rochester Regional Health, Jing Zhang, et al.
7-1-2026 Impact of Pulmonary Rehabilitation on Physical Functioning, Exercise Capacity and Sleep Disturbances in Post-tuberculosis Cases: A systematic Review, C K. Safareena, Shahzaad Hussain, Shweta Jha, et al.
7-1-2026 Isolated Extreme Thrombocytosis as the Presenting Feature of Chronic Myeloid Leukemia-An Unusual Phenotype Treated With Plateletpheresis, Kavya Balusu, Rochester Regional Health; Abdullah A. Orakzai, Rochester Regional Health; and Farhan S. Imran, Rochester Regional Health
7-1-2026 Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia, Jiun-Lu Lin, Christine Hsu, Shao-Wei Lo, et al.
7-1-2026 Place of death patterns among patients with renal cell carcinoma in the United States: A 24-year nationwide analysis, Cher Ying Foo, Rochester Regional Health; Ojasav Sehrawat, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health